Ministry of Health: medicines for COVID-19 will be included in the list of vital items within a week

Population New Zealand opts in referendum for legalization of euthanasia

In a binding referendum, the people of New Zealand have chosen to make euthanasia legal under the law. Not all votes have yet...

Maduro affirms that Spain will become “the epicenter of the conspiracy” against Venezuela

The Venezuelan President, Nicolás Maduro, assured this Thursday that Spain will become "the epicenter of the conspiracy against Venezuela", after welcoming the opposition leader...

New Zealand approved euthanasia in a referendum – cannabis stimulus collapsed

In the run-up to the October parliamentary elections, New Zealand also held a referendum on legalizing euthanasia and cannabis.The New Zealand Parliament passed a...

Bolivian Assembly approves six criminal proceedings against Áñez

The Plurinational Legislative Assembly of Bolivia has approved the report of the special commission that investigated the cases of Sacaba and Senkata, for...

Spain sends formal protest to Venezuela over insults to ambassador

Spain has sent a formal protest to the Government of Venezuela in response to the recent insults leveled at the Spanish ambassador in...

The new regulation makes it possible during a pandemic to introduce into the list of essential drugs for the treatment of a new coronavirus infection on an accelerated basis. This was announced by the head of the Ministry of Health of Russia Mikhail Murashko during a visit to the National Medical Research Center for Transplantology and Artificial Organs named after V.I. Academician V.I.Shumakov.

“In the next week, the decision of the commission will be … They are already included in the methodological recommendations,” – leads TASS words by Mikhail Murashko.

Also the minister reportedthat the Federal Antimonopoly Service (FAS), together with the Ministry of Health, will regulate prices for some drugs used to treat a new coronavirus infection.

It was FAS earlier did a request for the reasonableness of the price of the company “Promomed” – the manufacturer of “Areplivira” (faripiravir), the cost of one package of which in retail starts at 12 320 rubles.

Since June this year, it has been included in the recommendations of the Ministry of Health for the treatment, diagnosis and prevention of a new coronavirus infection.

Favipiravir is also produced under the brands Avifavir (ChemRara and RDIF) and Coronavir (R-Pharm). Registration of drugs before the completion of all clinical trials provides for their use only when there is a threat of the spread of emergency situations or the spread of dangerous diseases and in a hospital setting.



Related Articles